Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
NVOX ETF — Defiance Daily Target 2X Long NVO ETF
Defiance Daily Target 2X Long NVO ETF (NVOX)
Updated October 16, 2026.
NVOX is an ETF linked to Novo Nordisk A/S (NVO). its expense ratio is 1.31%. Total return is -94.0% over the past 1.9 years, 32.4 points behind NVO at -61.6%.
Defiance Daily Target 2X Long NVO ETF is an actively managed ETF that uses derivatives to seek twice the daily percentage movement of Novo Nordisk A/S shares, making it a leveraged trading vehicle rather than a traditional investment fund. The fund does not distribute income and carries an expense ratio of 1.31%. It appeals to active traders seeking short-term leveraged exposure to Novo Nordisk, not to income investors or buy-and-hold portfolios.
NVOX dividend yield and income
Price as of 2026-10-16.
The payment date is 12/31/2026.
NVOX holdings and sector exposure
Holdings are not available for this snapshot.
Economic / reference exposure: NVO (physical holdings below may be collateral and options, not the reference asset itself).
NVOX performance versus NVO
Price and return data through 2026-10-16.
Total return is -94.0% over the past 1.9 years, 32.4 points behind NVO at -61.6%. Over the past year its total return — price change plus distributions reinvested — is -65.7%. Its deepest 1-year drawdown was 72.9%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -15.9% | — |
| 3M | -46.8% | — |
| 6M | -21.7% | — |
| YTD | -55.4% | — |
| 1Y | -65.7% | — |
| Since inception (1.9 years) | -94.0% | -77.70% |
NVOX key facts
- Issuer
- Defiance ETFs
- Asset type
- ETF
- Asset class
- Equity
- Inception date
- 12/02/2024
- Expense ratio
- 1.31%
- Distribution frequency
- None
- Last close
- $9.76 (as of 2026-10-16)
- AUM
- $41,902,747
- Average volume
- 344800.0
- Payment date
- 12/31/2026
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: Defiance ETFs or company page; Index: Novo Nordisk A/S (NVO); prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
NVOX risks and drawbacks
Total return has trailed NVO over the available window. The deepest 1-year drawdown on record here is 72.9%.
Who may consider NVOX — and who may not
It is a weaker fit for investors who need monthly cash flow (NVOX does not currently distribute); investors whose main goal is matching NVO total return. This is educational context, not a recommendation to buy or sell.
More on NVOX
Frequently asked questions
Does NVOX pay monthly?
No. NVOX does not currently distribute.
What is NVOX linked to?
NVOX is linked to Novo Nordisk A/S (NVO), not a broad market index.
What is NVOX's expense ratio?
NVOX's expense ratio is 1.31%.
When does NVOX pay a dividend?
NVOX does not currently distribute. The payment date is 12/31/2026.
How has NVOX performed?
Total return is -94.0% over the past 1.9 years, 32.4 points behind NVO at -61.6%. Over the past year its total return — price change plus distributions reinvested — is -65.7%. Its deepest 1-year drawdown was 72.9%.
More securities from Defiance ETFs.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.